AQUESTIVE THERAPEUTICS
5.0900
20-September-24 14:59:59
15 minutes delayed
Stocks
-0.1100
-2.12%
Today's range
5.0550 - 5.2900
ISIN
N/A
Source
NASDAQ
-
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
05 Mar 2024 16:05:49 By Nasdaq GlobeNewswire
-
21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 07:00:35 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
30 Jan 2024 07:00:27 By Nasdaq GlobeNewswire
-
05 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
06 Nov 2023 15:37:36 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Completes $45 Million Debt Refinancing
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update
09 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
20 Sep 2023 08:04:50 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
23 Aug 2023 07:00:42 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
07 Aug 2023 15:01:06 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference
02 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
-
27 Jul 2023 06:00:01 By Nasdaq GlobeNewswire
-
25 Jul 2023 15:01:00 By Nasdaq GlobeNewswire
-
06 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment
29 Jun 2023 07:42:55 By Nasdaq GlobeNewswire